Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation
- PMID: 34138505
- PMCID: PMC8441904
- DOI: 10.1111/1471-0528.16813
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation
Abstract
Objective: To explore the experiences of women in Scotland who accessed medical abortion at home up to 12 weeks' gestation, delivered via a telemedicine abortion service implemented in response to the coronavirus (COVID-19) pandemic, to identify areas for improvement and inform service provision.
Design: Qualitative interview study.
Setting: Abortion service in one National Health Service health board in Scotland.
Population or sample: Twenty women who accessed telemedicine abortion services and self-administered mifepristone and misoprostol at home up to 12 weeks' gestation.
Methods: Thematic analysis of semi-structured qualitative interviews, informed by the Framework analytic approach.
Main outcome measures: Women's experiences of accessing telemedicine for medical abortion at home, specifically: acceptability of the telephone consultation and remote support; views on no pre-abortion ultrasound scan; and self-administration of abortion medications at home.
Results: Novel study findings were three-fold: (1) participants valued the option of accessing abortion care via telemedicine and emphasised the benefits of providing a choice of telephone and in-person consultation to suit those with different life circumstances; (2) the quality of abortion care was enhanced by the telemedicine service in relation to access, comfort and flexibility, and ongoing telephone support; (3) participants described being comfortable with, and in some cases a preference for, not having an ultrasound scan.
Conclusions: This research demonstrates support for the continuation of telemedicine abortion services beyond the temporary arrangements in place during COVID-19, and lends weight to the argument that offering the option of telemedicine abortion care can enable women to access this essential health service. TWEETABLE ABSTRACT: #Telemedicine provision of medical #abortion at home up to 12 weeks' gestation is acceptable and highly valued by #women #Research #SRHR @nbw80 @doctorjjrw @jeniharden @cameronsharon @mrc_crh @edinuniusher.
Keywords: Health services research; qualitative research; teleconsultation/telehealth; termination of pregnancy; termination of pregnancy: medical; women’s experiences.
© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Similar articles
-
Self-management of first trimester medical termination of pregnancy: a qualitative study of women's experiences.BJOG. 2017 Dec;124(13):2001-2008. doi: 10.1111/1471-0528.14690. Epub 2017 Jun 14. BJOG. 2017. PMID: 28421651 Free PMC article.
-
Barriers to accessing abortion services and perspectives on using mifepristone and misoprostol at home in Great Britain.Contraception. 2018 Feb;97(2):177-183. doi: 10.1016/j.contraception.2017.09.003. Epub 2017 Sep 20. Contraception. 2018. PMID: 28941978 Free PMC article.
-
Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.Hum Reprod. 2010 May;25(5):1153-7. doi: 10.1093/humrep/deq037. Epub 2010 Feb 19. Hum Reprod. 2010. PMID: 20172871
-
Early medical abortion.Best Pract Res Clin Obstet Gynaecol. 2025 Mar;99:102588. doi: 10.1016/j.bpobgyn.2025.102588. Epub 2025 Feb 21. Best Pract Res Clin Obstet Gynaecol. 2025. PMID: 40015183 Review.
-
Women's voices and medical abortions: A review of the literature.Eur J Obstet Gynecol Reprod Biol. 2020 Jun;249:21-31. doi: 10.1016/j.ejogrb.2020.04.003. Epub 2020 Apr 8. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32348948 Review.
Cited by
-
Perspectives on Abortion Services, the Pre-Abortion Visit, and Telemedicine Abortion: A Qualitative Study in Sweden.Perspect Sex Reprod Health. 2025 Mar;57(1):36-44. doi: 10.1111/psrh.12290. Epub 2025 Jan 12. Perspect Sex Reprod Health. 2025. PMID: 39800999 Free PMC article.
-
Abortion services during the COVID-19 pandemic: a systematic review.Reprod Health. 2023 Apr 13;20(1):61. doi: 10.1186/s12978-023-01582-3. Reprod Health. 2023. PMID: 37055839 Free PMC article.
-
Provider Mistrust and Telemedicine Abortion Care Preferences Among Patients in Ohio, West Virginia, and Kentucky.Telemed J E Health. 2023 Mar;29(3):414-424. doi: 10.1089/tmj.2022.0101. Epub 2022 Jul 19. Telemed J E Health. 2023. PMID: 35856859 Free PMC article.
-
Pandemic preparedness means policy makers need to work with social scientists.Lancet. 2022 Aug 20;400(10352):547-549. doi: 10.1016/S0140-6736(22)00983-7. Epub 2022 May 30. Lancet. 2022. PMID: 35654080 Free PMC article. No abstract available.
-
Patient and health professional attitudes towards the use of telemedicine for abortion care in Britain: Findings from the SACHA study.Digit Health. 2024 Nov 3;10:20552076241288717. doi: 10.1177/20552076241288717. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 39502487 Free PMC article.
References
-
- Finch RE, McGeechan K, Johnstone A, Cameron S. Impact of self‐administration of misoprostol for early medical abortion: a prospective observational cohort study. BMJ Sex Reprod Health 2019;45:296. - PubMed
-
- Harden J, Ancian J, Cameron S, Boydell N. Women’s experiences of self‐administration of misoprostol at home as part of early medical abortion: a qualitative evaluation. BMJ Sex Reprod Health 2021;47:144–9. - PubMed
-
- The Abortion Act 1967—Approval of a Class of Place for Treatment for the Termination of Pregnancy (Wales) 2020, (2020).
-
- The Abortion Act 1967 (Place for Treatment for the Termination of Pregnancy) (Approval) (Scotland) 2020, (2020).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical